Clinical outcomes in patients with advanced NSCLC treated with targeted therapies, with actionable mutations identified by InVisionFirst ctDNA assay
Titel:
Clinical outcomes in patients with advanced NSCLC treated with targeted therapies, with actionable mutations identified by InVisionFirst ctDNA assay
Auteur:
Remon, J. Mezquita, L. Ortiz-Cuaran, S. Jovelet, C. Lacroix, L. Morris, C. Green, E. Saintigny, P. Besse, B. Swalduz, A. Howarth, K. Rouleau, E. De Kievit, F. Baker-Neblett, K. Roitt, S. Plagnol, V. Perol, M. Planchard, D.